ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Crosstalk Therapeutics Ltd

Crosstalk Therapeutics Ltd is an active company incorporated on 27 January 2021 with the registered office located in Sandwich, Kent. Crosstalk Therapeutics Ltd was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13162770
Private limited company
Age
4 years
Incorporated 27 January 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 28 January 2025 (7 months ago)
Next confirmation dated 28 January 2026
Due by 11 February 2026 (5 months remaining)
Last change occurred 5 months ago
Accounts
Due Soon
For period 1 Feb31 Dec 2023 (11 months)
Accounts type is Small
Next accounts for period 31 December 2024
Due by 30 September 2025 (22 days remaining)
Contact
Address
Innovation House Innovation Way
Discovery Park
Sandwich
Kent
CT13 9FF
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
6
Shareholders
1
Controllers (PSC)
1
Director • Director • British • Lives in England • Born in Mar 1986
Director • Venture Capitalist • American • Lives in United States • Born in Oct 1986
Director • Scientist • Australian • Lives in UK • Born in Nov 1969
Director • Italian • Lives in UK • Born in Feb 1985
Director • Principal, Atlas Venture • American • Lives in United States • Born in Jan 1986
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Medicxi Ventures (UK) LLP
Dr Giovanni Mariggi and Nicholas Alexander Williams are mutual people.
Active
Vicebio Limited
Dr Giovanni Mariggi is a mutual person.
Active
Podium Bio Limited
Nicholas Alexander Williams is a mutual person.
Active
My-T Bio Limited
Dr Giovanni Mariggi is a mutual person.
Active
Interact Bio Ltd
Dr Giovanni Mariggi is a mutual person.
Active
Exigent Therapeutics Limited
Dr Giovanni Mariggi is a mutual person.
Active
Quilt Bio Limited
Nicholas Alexander Williams is a mutual person.
Active
Inhibitaxin Limited
Simon Lempriere Westbrook is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2022–2023)
Period Ended
31 Dec 2023
For period 31 Jan31 Dec 2023
Traded for 11 months
Cash in Bank
£683.18K
Increased by £588.73K (+623%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£732.89K
Increased by £524.76K (+252%)
Total Liabilities
-£3.35M
Increased by £2.1M (+168%)
Net Assets
-£2.62M
Decreased by £1.58M (+151%)
Debt Ratio (%)
457%
Decreased by 142.93% (-24%)
Latest Activity
Confirmation Submitted
5 Months Ago on 12 Mar 2025
Notification of PSC Statement
5 Months Ago on 12 Mar 2025
Mr Nicholas Alexander Williams Details Changed
7 Months Ago on 28 Jan 2025
Small Accounts Submitted
10 Months Ago on 1 Nov 2024
Accounting Period Shortened
1 Year Ago on 15 Aug 2024
Medicxi Iii Lp (PSC) Resigned
1 Year 2 Months Ago on 20 Jun 2024
Dr Jernej Godec Appointed
1 Year 2 Months Ago on 20 Jun 2024
President Michael Gladstone Appointed
1 Year 2 Months Ago on 20 Jun 2024
Simon Lempriere Westbrook Resigned
1 Year 2 Months Ago on 20 Jun 2024
Giovanni Mariggi Resigned
1 Year 2 Months Ago on 20 Jun 2024
Get Credit Report
Discover Crosstalk Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Mr Nicholas Alexander Williams on 28 January 2025
Submitted on 13 Mar 2025
Confirmation statement made on 28 January 2025 with updates
Submitted on 12 Mar 2025
Cessation of Medicxi Iii Lp as a person with significant control on 20 June 2024
Submitted on 12 Mar 2025
Notification of a person with significant control statement
Submitted on 12 Mar 2025
Accounts for a small company made up to 31 December 2023
Submitted on 1 Nov 2024
Previous accounting period shortened from 31 January 2024 to 31 December 2023
Submitted on 15 Aug 2024
Statement of capital following an allotment of shares on 20 June 2024
Submitted on 17 Jul 2024
Statement of capital following an allotment of shares on 20 June 2024
Submitted on 16 Jul 2024
Appointment of President Michael Gladstone as a director on 20 June 2024
Submitted on 12 Jul 2024
Appointment of Dr Jernej Godec as a director on 20 June 2024
Submitted on 12 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year